CHICAGO, IL — 400 N Elizabeth Street is one of the most ambitious proposals to-date for a new life sciences development in Chicago. The SCB-designed project will bring 500,000-square-feet of lab and office space to the city’s Fulton Market district. “Endowed with a technical workforce, skilled scientists, top-notch research hospitals and universities, infrastructure and capital for high-tech start-ups and a vibrant urban locale, the city already has the essential elements to attract life sciences investment and this building completes the offering,” said says developer Mark Goodman. “We’ve assembled a ‘dream team’ of experts . . . to ensure we design and deliver a best-in-class facility that propels Chicago to the forefront as a top-tier life sciences hub.”

Read more about the proposed project and the city’s burgeoning life sciences market in Crain’s Chicago Business